CN1086997A - 一种使用血管舒张药的治疗方法 - Google Patents

一种使用血管舒张药的治疗方法 Download PDF

Info

Publication number
CN1086997A
CN1086997A CN93116247A CN93116247A CN1086997A CN 1086997 A CN1086997 A CN 1086997A CN 93116247 A CN93116247 A CN 93116247A CN 93116247 A CN93116247 A CN 93116247A CN 1086997 A CN1086997 A CN 1086997A
Authority
CN
China
Prior art keywords
nitrites
accordance
patient
angina pectoris
dosage
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN93116247A
Other languages
English (en)
Chinese (zh)
Inventor
H·L·芳格
J·A·保尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Teva Branded Pharmaceutical Products R&D Inc
Original Assignee
Baker Cummins Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baker Cummins Pharmaceuticals Inc filed Critical Baker Cummins Pharmaceuticals Inc
Publication of CN1086997A publication Critical patent/CN1086997A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CN93116247A 1992-07-02 1993-07-02 一种使用血管舒张药的治疗方法 Pending CN1086997A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/908,224 1992-07-02
US07/908,224 US5278192A (en) 1992-07-02 1992-07-02 Method of vasodilator therapy for treating a patient with a condition

Publications (1)

Publication Number Publication Date
CN1086997A true CN1086997A (zh) 1994-05-25

Family

ID=25425396

Family Applications (1)

Application Number Title Priority Date Filing Date
CN93116247A Pending CN1086997A (zh) 1992-07-02 1993-07-02 一种使用血管舒张药的治疗方法

Country Status (19)

Country Link
US (2) US5278192A (enExample)
EP (1) EP0604642A1 (enExample)
JP (1) JP2729333B2 (enExample)
KR (1) KR0170789B1 (enExample)
CN (1) CN1086997A (enExample)
AU (1) AU667948B2 (enExample)
CA (1) CA2116785C (enExample)
CZ (1) CZ39894A3 (enExample)
HU (1) HUT70501A (enExample)
IL (1) IL106217A (enExample)
MX (1) MX9303982A (enExample)
NO (1) NO305886B1 (enExample)
NZ (1) NZ254490A (enExample)
OA (1) OA09890A (enExample)
PL (1) PL302613A1 (enExample)
SK (1) SK23594A3 (enExample)
TW (1) TW261530B (enExample)
WO (1) WO1994001103A1 (enExample)
ZA (1) ZA934771B (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113164427A (zh) * 2018-11-27 2021-07-23 阿特格诺有限公司 用于制备亚硝基化丙二醇的方法、包含其的组合物及其医学用途

Families Citing this family (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5646181A (en) * 1992-07-02 1997-07-08 Research Foundation Of State University Of New York Method and compositions for treating impotence
US5278192A (en) * 1992-07-02 1994-01-11 The Research Foundation Of State University Of New York Method of vasodilator therapy for treating a patient with a condition
GB9311920D0 (en) 1993-06-09 1993-07-28 Pfizer Ltd Therapeutic agents
US5973011A (en) * 1994-03-30 1999-10-26 Isis Pharma Gmbh Pharmaceutical preparations and medicaments for the prevention and treatment of endothelial dysfunction
US5681278A (en) * 1994-06-23 1997-10-28 Cormedics Corp. Coronary vasculature treatment method
US5594032A (en) * 1994-11-10 1997-01-14 Gonzalez-Cadavid; Nestor F. Amelioration of human erectile dysfunction by treatment with iNOS, inducers of iNOS or iNOS cDNA
US5665077A (en) * 1995-04-24 1997-09-09 Nitrosci Pharmaceuticals Llc Nitric oxide-releasing nitroso compositions and methods and intravascular devices for using them to prevent restenosis
US5645839A (en) * 1995-06-07 1997-07-08 Trustees Of Boston University Combined use of angiotensin inhibitors and nitric oxide stimulators to treat fibrosis
US5658936A (en) * 1995-09-18 1997-08-19 Brigham & Women's Hospital, Inc. Enhancement of erectile function with renin-angiotensin system inhibitors
US6036977A (en) * 1995-09-29 2000-03-14 L.A.M. Pharmaceutical Corp. Drug preparations for treating sexual dysfunction
US6251436B1 (en) 1995-09-29 2001-06-26 L.A.M. Pharmaceutical Corporation Drug preparations for treating sexual dysfunction
US5897880A (en) 1995-09-29 1999-04-27 Lam Pharmaceuticals, Llc. Topical drug preparations
US6387407B1 (en) 1995-09-29 2002-05-14 L.A.M. Pharmaceutical Corporation Topical drug preparations
WO1997027745A1 (en) * 1996-01-31 1997-08-07 Technology Licensing Co. L.L.C. Method of diagnosis and treatment and related compositions and apparatus
US6258032B1 (en) * 1997-01-29 2001-07-10 William M. Hammesfahr Method of diagnosis and treatment and related compositions and apparatus
GB9608408D0 (en) 1996-04-23 1996-06-26 Adams Michael A Treatment of erectile dysfunction
US5797887A (en) * 1996-08-27 1998-08-25 Novovasc Llc Medical device with a surface adapted for exposure to a blood stream which is coated with a polymer containing a nitrosyl-containing organo-metallic compound which releases nitric oxide from the coating to mediate platelet aggregation
US5958884A (en) * 1997-04-11 1999-09-28 The Brigham And Women's Hospital, Inc. Compositions and methods for treating erectile dysfunction
US6191156B1 (en) 1997-04-11 2001-02-20 The Brigham And Women's Hospital, Inc. Compositions and methods for treating bladder dysfunction
ZA989356B (en) * 1997-10-16 1998-11-16 Isis Pharma Gmbh Pharmaceutical preparations
US6056966A (en) * 1998-05-18 2000-05-02 Baker Norton Pharmaceuticals, Inc. Method and compositions for treating impotence
US6314956B1 (en) * 1999-09-08 2001-11-13 Duke University Pulmonary delivery of NO group-containing compound in gas form to treat respiratory, cardiac and blood disorders
US7045152B2 (en) 1999-09-08 2006-05-16 Duke University Treating pulmonary disorders with gaseous agent causing repletion of GSNO
EP1301500B1 (en) 2000-06-22 2007-11-21 Nitromed, Inc. Nitrosated and nitrosylated taxanes, compositions and methods of use
CN1267212C (zh) 2000-08-11 2006-08-02 大卫·R·怀特洛克 氨氧化细菌在药物中的应用、由其制成的制剂及用其处理过的用品
US20020172712A1 (en) * 2001-03-19 2002-11-21 Alan Drizen Antiemetic, anti-motion sustained release drug delivery system
US7235523B2 (en) * 2001-04-13 2007-06-26 Children's Hospital Medical Center Methods for the treatment of hepatic disorders
US20030026830A1 (en) * 2001-05-08 2003-02-06 Thomas Lauterback Transdermal therapeutic system for parkinson's disease inducing high plasma levels of rotigotine
US20030027793A1 (en) * 2001-05-08 2003-02-06 Thomas Lauterback Transdermal treatment of parkinson's disease
US20030138494A1 (en) * 2001-05-15 2003-07-24 L.A.M. Pharmaceutical Corporation Drug preparations for treating sexual dysfunction
US20040225275A1 (en) * 2001-08-02 2004-11-11 Reynolds James Dixon Fetal physiology during maternal surgery or diagnosis
US6676855B2 (en) * 2001-08-02 2004-01-13 Duke University Use of a blood-flow decrease preventing agent in conjunction with insufflating gas
US20050244382A9 (en) * 2002-01-11 2005-11-03 Whitlock David R Compositions including ammonia oxidizing bacteria and methods of using same
US7776925B2 (en) * 2002-03-06 2010-08-17 Duke University Reversing, postponing or preventing the occurrence of GTN tolerance and/or generation of reactive oxygen species from mitochondria
CA2478089A1 (en) 2002-03-06 2003-09-18 Duke University Methods and composition based on discovery of metabolism of nitroclycerin
US20060263419A1 (en) * 2002-03-12 2006-11-23 Hans-Michael Wolff Transdermal therapeutic system for Parkinson's Disease
US20040063717A1 (en) 2002-05-21 2004-04-01 Andrew Wolff Method of treating diabetes
US8822473B2 (en) * 2002-05-21 2014-09-02 Gilead Sciences, Inc. Method of treating diabetes
US6936639B2 (en) * 2002-08-21 2005-08-30 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Nitroxyl progenitors in the treatment of heart failure
WO2005063221A1 (en) * 2003-12-19 2005-07-14 Duke University Measuring vasodilating activity of blood samples to track disease course
EP1865770A4 (en) * 2005-04-07 2010-12-29 Nitromed Inc ASSESSMENT OF GENETIC RISK IN CARDIAC ERRORS: IMPACT OF THE GENETIC VARIATION OF NOS3
US20090209613A1 (en) * 2005-06-13 2009-08-20 Yeda Researc And Development Co. Ltd. At The Weizmann Institute Of Science Use of allymercaptocaptopril for treating or preventing obesity and obesity related diseases
US20090054381A1 (en) * 2005-10-04 2009-02-26 Nitromed, Inc. Methods for treating respiratory disorders
ATE534618T1 (de) * 2006-03-14 2011-12-15 Lars E Gustafsson Neues verfahren zur herstellung therapeutischer verbindungen und zusammensetzungen, dadurch hergestellte verbindungen und zusammensetzungen und deren verwendung
US7625852B2 (en) * 2006-06-07 2009-12-01 Henry Hadry Nail polish remover
US11229746B2 (en) 2006-06-22 2022-01-25 Excelsior Medical Corporation Antiseptic cap
US9259535B2 (en) 2006-06-22 2016-02-16 Excelsior Medical Corporation Antiseptic cap equipped syringe
US9649334B2 (en) 2007-11-15 2017-05-16 The Uab Research Foundation Use of nitrite salts in chronic ischemia
US9078992B2 (en) 2008-10-27 2015-07-14 Pursuit Vascular, Inc. Medical device for applying antimicrobial to proximal end of catheter
US20120237617A1 (en) 2009-06-18 2012-09-20 Theravasc Inc. Use of nitrite salts in treating tissue damage
US10463689B2 (en) 2009-10-14 2019-11-05 Board Of Supervisors Of Louisiana State University Pharmaceutical formulations of nitrite and uses thereof
US20110160200A1 (en) * 2009-11-23 2011-06-30 Cardioxyl Pharmaceuticals, Inc. Nitroxyl Progenitors for the Treatment of Pulmonary Hypertension
AU2010328234B2 (en) * 2009-12-07 2016-05-12 Cardioxyl Pharmaceuticals, Inc. N-acyloxysulfonamide and N-hydroxy-N-acylsulfonamide derivatives
AU2010328230B2 (en) 2009-12-07 2016-06-02 Cardioxyl Pharmaceuticals, Inc. Bis-acylated hydroxylamine derivatives
US10166381B2 (en) 2011-05-23 2019-01-01 Excelsior Medical Corporation Antiseptic cap
ES2797649T3 (es) 2011-07-12 2020-12-03 Icu Medical Inc Dispositivo para entrega de agente antimicrobiano en un catéter transdérmico
HK1214136A1 (zh) * 2012-08-23 2016-07-22 Cardiolynx Ag 硝酸氨基烷基酯的延长释放组合物
CN105358160A (zh) 2013-02-20 2016-02-24 瑟阿瓦斯克公司 亚硝酸盐的药物制剂及其用途
US11225640B2 (en) 2014-04-15 2022-01-18 Aobiome Llc Ammonia oxidizing bacteria for treatment of psoriasis
WO2015160911A2 (en) 2014-04-15 2015-10-22 Aobiome Llc Ammonia-oxidizing nitrosomonas eutropha strain d23
EP3137122B1 (en) 2014-05-02 2019-09-04 Excelsior Medical Corporation Strip package for antiseptic cap
WO2016182822A1 (en) 2015-05-08 2016-11-17 Icu Medical, Inc. Medical connectors configured to receive emitters of therapeutic agents
CA3040277C (en) 2016-10-14 2025-08-12 Icu Medical Inc Sanitizing caps for medical connectors
WO2018204206A2 (en) 2017-05-01 2018-11-08 Icu Medical, Inc. Medical fluid connectors and methods for providing additives in medical fluid lines
US11534595B2 (en) 2018-11-07 2022-12-27 Icu Medical, Inc. Device for delivering an antimicrobial composition into an infusion device
US11541220B2 (en) 2018-11-07 2023-01-03 Icu Medical, Inc. Needleless connector with antimicrobial properties
US11541221B2 (en) 2018-11-07 2023-01-03 Icu Medical, Inc. Tubing set with antimicrobial properties
US11400195B2 (en) 2018-11-07 2022-08-02 Icu Medical, Inc. Peritoneal dialysis transfer set with antimicrobial properties
US11517732B2 (en) 2018-11-07 2022-12-06 Icu Medical, Inc. Syringe with antimicrobial properties
US11433215B2 (en) 2018-11-21 2022-09-06 Icu Medical, Inc. Antimicrobial device comprising a cap with ring and insert
GB202007929D0 (en) * 2020-05-27 2020-07-08 Attgeno Ab New medical uses
WO2022072663A1 (en) * 2020-10-01 2022-04-07 Emergent Product Development Gaithersburg Inc. Stabilized alkyl nitrite compositions
AU2021396147A1 (en) 2020-12-07 2023-06-29 Icu Medical, Inc. Peritoneal dialysis caps, systems and methods

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3106511A (en) * 1961-12-14 1963-10-08 Revlon Amyl nitrite inhalant composition
CA1163195A (en) * 1980-06-26 1984-03-06 Alec D. Keith Polymeric diffusion matrix containing a vasodilator
US4450175A (en) * 1982-09-23 1984-05-22 Warshaw Thelma G Method and compositions for treating acne
DE3305690A1 (de) * 1983-02-18 1984-08-30 Heinrich Mack Nachf., 7918 Illertissen Glycerinmononitrate zur behandlung der angina pectoris
US4751087A (en) * 1985-04-19 1988-06-14 Riker Laboratories, Inc. Transdermal nitroglycerin delivery system
US4681584A (en) * 1985-05-03 1987-07-21 Alza Corporation Transdermal delivery system for delivering nitroglycerin at high transdermal fluxes
US4615699A (en) * 1985-05-03 1986-10-07 Alza Corporation Transdermal delivery system for delivering nitroglycerin at high transdermal fluxes
JPH06697B2 (ja) * 1987-01-27 1994-01-05 積水化学工業株式会社 テ−プ製剤
JPH06696B2 (ja) * 1987-01-27 1994-01-05 積水化学工業株式会社 テ−プ製剤
US4956181A (en) * 1987-05-08 1990-09-11 Eastman Kodak Nitrate therapy for angina pectoris
US5278192A (en) * 1992-07-02 1994-01-11 The Research Foundation Of State University Of New York Method of vasodilator therapy for treating a patient with a condition

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113164427A (zh) * 2018-11-27 2021-07-23 阿特格诺有限公司 用于制备亚硝基化丙二醇的方法、包含其的组合物及其医学用途

Also Published As

Publication number Publication date
NO940691L (no) 1994-03-18
NO940691D0 (no) 1994-02-28
HU9400627D0 (en) 1994-06-28
CA2116785C (en) 1998-04-07
US5278192A (en) 1994-01-11
IL106217A0 (en) 1993-11-15
EP0604642A1 (en) 1994-07-06
IL106217A (en) 1998-04-05
HUT70501A (en) 1995-10-30
US5489610A (en) 1996-02-06
JPH06510800A (ja) 1994-12-01
OA09890A (en) 1994-09-15
SK23594A3 (en) 1994-08-10
WO1994001103A1 (en) 1994-01-20
PL302613A1 (en) 1994-09-05
CZ39894A3 (en) 1994-11-16
TW261530B (enExample) 1995-11-01
AU667948B2 (en) 1996-04-18
CA2116785A1 (en) 1994-01-20
NZ254490A (en) 1997-08-22
KR0170789B1 (ko) 1999-02-01
MX9303982A (es) 1994-02-28
NO305886B1 (no) 1999-08-16
ZA934771B (en) 1994-01-20
JP2729333B2 (ja) 1998-03-18
AU4658793A (en) 1994-01-31

Similar Documents

Publication Publication Date Title
CN1086997A (zh) 一种使用血管舒张药的治疗方法
Lemmer et al. Chronopharmacology and chronotherapeutics: definitions and concepts
Lemmer Circadian rhythms and drug delivery
CN1127473A (zh) 以促孕剂和氧化氮合酶底物和/或供体的结合物治疗子痫前期和早产
CN1227029C (zh) 转化酶抑制剂和利尿剂的组合在治疗微循环紊乱中的应用
CN1181699A (zh) 用于治疗心血管疾病的氨基四氢化萘衍生物
RU2071771C1 (ru) Способ лечения рака молочной железы
CN118512434A (zh) N-乳酰苯丙氨酸在制备防治缺血性心脏病药物中的用途
Payne et al. The effects of mecamylamine in the cat as modified by the administration of carbon dioxide
BRUNGARDT et al. Adrenergic mechanisms in canine hindlimb circulation
CN102670597B (zh) 5-(4-羟基-3-甲氧基苯亚甲基)罗丹宁在制备治疗帕金森氏病药物中的用途
Noori et al. Coincidence of Events Causing Paradoxical Hypotension in a Patient with an Intra-Aortic Balloon Pump
CN1102853C (zh) 癌转移抑制剂及动物用癌转移抑制剂
CN104586835B (zh) 穿心莲内酯的医药用途
US12419887B2 (en) Transitioning patients treated for pulmonary arterial hypertension to selexipag
RU2065744C1 (ru) Способ лечения гипертонической болезни ii стадии
SU1097334A1 (ru) Способ лечени ишемической болезни сердца
RU2135178C1 (ru) Способ повышения противоопухолевой эффективности в эксперименте
Allon et al. Prolonged hypotension after initial minoxidil dose
Puybasset et al. Coronary effects of exogenous and endogenous bradykinin in conscious dogs
SU1210847A1 (ru) Способ лечени больных псориатическим артритом
CN1308008C (zh) 治疗冠心病的药物组合物
RU2219930C2 (ru) Способ лечения заболеваний печени
Voelkel Drug effects on the pulmonary circulation: an overview
CN120227382A (zh) 依普利酮在制备治疗类风湿性关节炎的药物中的应用

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication